Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010
…, R Krishnamurthi, GA Mensah, M Connor… - The lancet, 2014 - thelancet.com
Background Although stroke is the second leading cause of death worldwide, no
comprehensive and comparable assessment of incidence, prevalence, mortality, disability, and …
comprehensive and comparable assessment of incidence, prevalence, mortality, disability, and …
[HTML][HTML] Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010
…, MH Forouzanfar, GA Mensah, M Connor… - The Lancet Global …, 2013 - thelancet.com
Background The burden of ischaemic and haemorrhagic stroke varies between regions and
over time. With differences in prognosis, prevalence of risk factors, and treatment strategies, …
over time. With differences in prognosis, prevalence of risk factors, and treatment strategies, …
[HTML][HTML] COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup
…, MJ Connor Jr, KD Liu, M Ostermann… - Nature reviews …, 2020 - nature.com
Kidney involvement in patients with coronavirus disease 2019 (COVID-19) is common, and
can range from the presence of proteinuria and haematuria to acute kidney injury (AKI) …
can range from the presence of proteinuria and haematuria to acute kidney injury (AKI) …
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
…, MD Connor, LT Cooper, M Corriere, M Cortinovis… - The lancet, 2012 - thelancet.com
Background Measuring disease and injury burden in populations requires a composite metric
that captures both premature mortality and the prevalence and severity of ill-health. The …
that captures both premature mortality and the prevalence and severity of ill-health. The …
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
…, MD Connor, LT Cooper, M Corriere, M Cortinovis… - The lancet, 2012 - thelancet.com
Background Non-fatal health outcomes from diseases and injuries are a crucial consideration
in the promotion and monitoring of individual and population health. The Global Burden of …
in the promotion and monitoring of individual and population health. The Global Burden of …
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
…, MD Connor, LT Cooper, M Corriere, M Cortinovis… - The lancet, 2012 - thelancet.com
Background Reliable and timely information on the leading causes of death in populations,
and how these are changing, is a crucial input into health policy debates. In the Global …
and how these are changing, is a crucial input into health policy debates. In the Global …
Metabolic engineering of Escherichia coli for 1-butanol production
Compared to ethanol, butanol offers many advantages as a substitute for gasoline because
of higher energy content and higher hydrophobicity. Typically, 1-butanol is produced by …
of higher energy content and higher hydrophobicity. Typically, 1-butanol is produced by …
Effects of daily hassles and eating style on eating behavior.
Objective: This study investigated the daily hassles-eating behavior relationship and its
moderators in a naturalistic setting. Design: A multilevel diary design was used to examine day-to…
moderators in a naturalistic setting. Design: A multilevel diary design was used to examine day-to…
PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest
…, J Zubovitz, T Petrocelli, R Kotchetkov, MK Connor… - Nature medicine, 2002 - nature.com
Mechanisms linking mitogenic and growth inhibitory cytokine signaling and the cell cycle
have not been fully elucidated in either cancer or in normal cells. Here we show that activation …
have not been fully elucidated in either cancer or in normal cells. Here we show that activation …
[HTML][HTML] Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP …
…, S Roberts, J Harrison, L Marsh, M Connor… - The Lancet …, 2021 - thelancet.com
Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …